Ligand validation:4ISF

GLC: alpha-D-glucopyranose

GLC is a Ligand Of Interest in 4ISF designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4ISF_GLC_A_500	81%	71%	0.097	0.948	0.41	0.7	-	-	0	0	100%	1
3VEV_GLC_A_501	95%	37%	0.076	0.98	1.35	1.14	2	1	0	0	100%	1
4DCH_GLC_A_501	93%	59%	0.082	0.978	0.7	0.85	-	1	0	0	100%	1
3S41_GLC_A_500	92%	36%	0.085	0.975	1.44	1.1	2	1	1	0	100%	1
3GOI_GLC_A_2	90%	14%	0.097	0.98	1.37	2.44	1	9	1	0	100%	1
4IXC_GLC_A_502	87%	56%	0.096	0.969	0.61	1.07	-	2	0	0	100%	1
5O59_GLC_A_608	100%	61%	0.025	0.992	0.81	0.69	-	-	0	0	92%	0.9167
8R4G_GLC_C_1001	100%	39%	0.042	0.991	0.8	1.57	1	3	1	0	100%	1
5MTT_GLC_A_407	98%	66%	0.053	0.993	0.38	0.92	-	-	0	0	92%	0.5867
2WYN_GLC_C_1548	98%	56%	0.059	0.979	0.65	1.02	-	1	0	0	100%	1
2JJB_GLC_D_1548	98%	55%	0.07	0.989	0.73	1	-	2	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.